Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs conventional ovarian stimulation for fertility preservation in breast cancer
ChiCTR2300078625Phase 4Not yet recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of letrozole in breast cancer (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: number of mature oocytes. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR2300078625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078625.